Actinium Pharmaceuticals, Inc. 4
4 · Actinium Pharmaceuticals, Inc. · Filed Mar 16, 2017
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Award
Options to purchase common stock
2017-03-14$1.39/sh+250,000$347,500→ 250,000 totalExercise: $1.39Exp: 2027-03-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant. In addition, 100,000 options are subject to cancellation based on the obtainment of certain milestones.